Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08FDI
|
|||
| Former ID |
DNC005201
|
|||
| Drug Name |
3-(2-Pyridin-2-yl-2H-tetrazol-5-yl)-benzonitrile
|
|||
| Synonyms |
CHEMBL366288; 3-(2-Pyridin-2-yl-2H-tetrazol-5-yl)-benzonitrile; SCHEMBL4703496; ZINC13582347
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H8N6
|
|||
| Canonical SMILES |
C1=CC=NC(=C1)N2N=C(N=N2)C3=CC=CC(=C3)C#N
|
|||
| InChI |
1S/C13H8N6/c14-9-10-4-3-5-11(8-10)13-16-18-19(17-13)12-6-1-2-7-15-12/h1-8H
|
|||
| InChIKey |
GHRSDAGWCBAULR-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity. J Med Chem. 2004 Sep 9;47(19):4645-8. Letter | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.